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Abstract
It had been thought that quantal size in synaptic transmission
is invariable. Evidence has been emerging, however, that
quantal size can be varied under certain conditions. We
present evidence that alteration in vesicular [3H]L-glutamate
(Glu) content within the synaptosome (a pinched-off nerve
ending preparation) leads to a change in the amount of
exocytotically released [3H]Glu. We found that Rose Bengal, a
polyhalogenated ¯uorescein derivative, is a quite potent
membrane-permeant inhibitor (Ki  19 nM) of glutamate
uptake into isolated synaptic vesicles. This vesicular Glu
uptake inhibition was achieved largely without affecting H1-
pump ATPase. We show that various degrees of reduction
elicited by Rose Bengal in [3H]Glu in synaptic vesicles inside
the synaptosome result in a corresponding decrease in the
amount of [3H]Glu released in a depolarization- (induced by 4-
aminopyridine) and Ca21-dependent manner. In contrast,
¯uorescein, the halogen-free analog of Rose Bengal, which is
devoid of inhibitory activity on vesicular [3H]Glu uptake, failed to
change the amount of exocytotically released [3H]Glu. These
observations suggest that glutamate synaptic transmission
could be altered by pharmacological intervention of glutamate
uptake into synaptic vesicles in the nerve terminal, a new
mode of synaptic manipulation for glutamate transmission.
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The common biochemical l-glutamate (Glu) is now widely
recognized as the major excitatory neurotransmitter in the
vertebrate CNS (Fonnum 1984; Cotman et al. 1988;
Watkins et al. 1990). Proper Glu transmission plays a key
role in physiological brain functions such as learning and
memory formation, as well as basic neural communication
(Cotman et al. 1988; Collingridge and Singer 1990),
whereas aberrant Glu transmission appears to be involved
in various neurological and psychiatric disorders, such as
certain forms of epilepsy, ischemic brain injury, Parkinson's
disease, Alzheimer's disease and schizophrenia (Meldrum
1985; Choi 1988; Javitt and Zukin 1991; Zorumski and
Olney 1993; Lipton and Rosenberg 1994; Bradford 1995;
Bunney et al. 1995; Olney and Farber 1995; Coyle 1996;
Chapman 1998). Presynaptically, synaptic vesicles play a
pivotal role in Glu synaptic transmission (Ueda 1986;
Nicholls 1989; Maycox et al. 1990; OÈ zkan and Ueda 1998).
l-Glutamate is accumulated into isolated synaptic vesicles
in a highly speci®c and ATP-dependent manner, utilizing
the electrochemical proton gradient generated by V-type
proton-pump ATPase (Naito and Ueda 1983, 1985; Maycox
et al. 1988; Cidon and Sihra 1989; Fykse et al. 1989; Tabb
et al. 1992), and has been shown to be concentrated in
synaptic vesicles in vivo (Storm-Mathisen et al. 1983;
Burger et al. 1989). Under normal physiological conditions,
Glu is released from synaptic vesicles in the nerve terminal
by a Ca21-signaled exocytotic mechanism, but not from the
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cytoplasmic pool (Nicholls and Sihra 1986; Kish and Ueda
1991; McMahon and Nicholls 1991; Mehta et al. 1996).
Vesicular accumulation of Glu is thought to play a crucial
role in directing the common biochemical Glu to the
neurotransmitter pathway, diverting it from the general
metabolic pathway (Ueda 1986; OÈ zkan and Ueda 1998).
It has been reported that vesicular glutamate uptake is
inhibited by certain glutamate analogs (Naito and Ueda
1985; Winter and Ueda 1993), ergopeptides (Carlson et al.
1989; Moriyama et al. 1991) and kynurenate-related
compounds (Fykse et al. 1992; Bartlett et al. 1998; Carrigan
et al. 1999). Roseth et al. (1995, 1998) found that
xenobiotic, anionic dyes, such as Evans Blue, Chicago
Sky Blue 6B and Trypan Blue, are potent competitive
inhibitors of Glu uptake into isolated synaptic vesicles.
OÈ zkan et al. (1997) showed that an elongated protein,
referred to as IPF, inhibits vesicular glutamate uptake with
high potency. However, it remains to be seen whether any of
the compounds mentioned above is effective, when applied
extracellularly, in leading to a decrease in Glu released upon
stimulation of the nerve terminal. A substance which is
taken up into nerve endings and affects vesicular Glu
storage would provide a new way of manipulating the
amount of evoked release of Glu. Demonstration of such an
agent may stimulate a new approach to developing lead
compounds for creating therapeutically useful agents
targeting certain CNS diseases involving abnormal Glu
synaptic transmission.
Here we report that the hydrophobic, membrane-permeant
dye Rose Bengal, a polyhalogenated ¯uorescein derivative,
is remarkably potent in inhibiting Glu uptake into isolated
synaptic vesicles. We present evidence that, when incubated
with synaptosomes, Rose Bengal causes a dose-dependent
reduction in vesicular Glu content and diminishes the
amount of exocytotically released Glu.
Materials and methods
Preparation of synaptic vesicles and synaptosomes
Rat crude synaptic vesicles (RCSV) were prepared as described by
Kish and Ueda (1989), with minor modi®cations. ATP-dependent
Glu uptake activity was generally 400±500 pmol/mg/10 min under
our standard assay conditions, and represented 85±90% of the total
activity (i.e. activity in the presence of ATP) in the RCSV.
Crude synaptosomes were prepared using a modi®cation of the
method of Krueger et al. (1977) from male Sprague2Dawley rat
(200±250 g) cerebrum. The ®nal pellets were then suspended by
gently pipetting in 15 mL of oxygenated (95% O2/5% CO2)
arti®cial CSF, consisting of 124 mm NaCl, 5 mm KCl, 2 mm
MgSO4, 1.25 mm NaH2PO4, 2 mm CaCl2, 22 mm NaHCO3 and
10 mm d-glucose. These suspensions were used as the synapto-
somal preparation within 8 h for the studies described here. These
procedures were all carried out at 48C or on ice. The synaptosomal
preparations contained proteins at a concentration of 1±1.5 mg/mL.
Protein concentrations were determined using the Coomassie
Protein Assay kit from Pierce, with bovine serum albumin as
standard. Buffers and any other solutions used in this study were all
sterilized immediately before use by ®ltration through a nitrocellu-
lose membrane (pore size 0.45 mm), to avoid possible microbial
contamination (Yoneda and Ogita 1989).
l-Glutamate uptake into synaptic vesicles
Vesicular Glu uptake was assayed as described previously by Naito
and Ueda (1983, 1985) with minor modi®cations. Aliquots (30±
40 mg) of RCSV were incubated at 308C with 50 mm [3H]Glu (a
speci®c activity of 7.4 GBq/mmol was obtained by addition of
unlabeled Glu to [G-3H]Glu with a speci®c activity of 2.33 TBq/
mmol, Amersham Life Science, Buckinghamshire, UK) in 0.1 mL
of an incubation medium (pH 7.4) containing 20 mm HEPES-
KOH, 0.25 m sucrose, 4 mm MgSO4, 4 mm KCl and 2 mm
l-aspartic acid (Asp) in the absence or presence of 2 mm ATP
(adjusted pH 7.4 by addition of Tris-base). For Lineweaver2Burk
analysis, aliquots of RCSV were incubated with [3H]Glu (74 kBq/
tube) at 308C for 2 min in the presence of seven different
concentrations of unlabeled Glu to cover a concentration range of
0.2±5 mm. Prior incubation without ATP, unlabeled Glu and
[3H]Glu was for 30 min at 308C. ATP-dependent Glu uptake
activity was calculated by subtracting uptake activity in the absence
of ATP from that in its presence. Test compounds Rose Bengal and
¯uorescein (Aldrich Chemicals, Milwaukee, WI, USA) were pre-
incubated at 308C for 30 min with RCSV in the incubation medium
lacking [3H]Glu, unlabeled Glu and ATP. All compounds tested
were dissolved in dimethylsulfoxide at a concentration of 5 mm;
the concentration of Rose Bengal, ¯uorescein and other ¯uorescein
analogs was determined spectrophotometrically. The ®nal concen-
tration of dimethylsulfoxide in reaction mixtures was kept at 1% or
less.
l-Glutamate release from synaptosomes
Aliquots (0.15±0.23 mg of protein) of synaptosomal preparations
were incubated with 50 nm [3H]Glu (2.33 TBq/mmol) in 1.5 mL
CSF at 378C for 10 min. [3H]Glu-loaded synaptosomal suspensions
(1.2 mL) were layered onto cellulose acetate membrane ®lters
(pore size 0.45 mm) placed in a superfusion chamber. The synapto-
somes were superfused (0.6 mL/min) with CSF for 40 min before
being subjected to depolarization with 50 mm 4-aminopyridine
(4-AP; Sigma, St Louis, MO, USA). When Ca21-independent
release was monitored, EGTA was substituted for CaCl2 (2 mm) in
CSF. These procedures were all carried out at 378C. In general,
three 30-s fractions containing Glu released by depolarization with
4-AP were collected. Prior to this, three 30-s fractions were
collected. The release observed during this period was de®ned to
represent basal release. Evoked release was calculated by subtract-
ing the amount of [3H]Glu released during the basal release period
(1.5 min) from the amount of [3H]Glu released during the 1.5-min
period after 4-AP application. In some experiments, fractions were
collected every 10 s in order to improve time resolution. The
amount of release into each fraction was expressed as a percentage
of either the total [3H]Glu taken up into synaptosomes at the end of
10-minute loading or the amount of [3H]Glu collected during the
basal release period. The total [3H]Glu loaded into synaptosomes
was estimated from the amount of [3H]Glu in 0.1 mL of loaded
synaptosomes, determined by the same ®ltration method used for
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the vesicular Glu uptake assay. Compounds tested were co-
incubated with synaptosomes during [3H]Glu loading. Similar
experiments indicated that at least 85% of radioactivity released
was recovered as Glu (Feasey et al. 1986). Under our experimental
conditions, at least 90% of radioactivity recovered in the vesicle
fraction was attributable to [3H]Glu.
l-Glutamate content in synaptic vesicles within the
synaptosome
Aliquots (0.1±0.15 mg of protein) of synaptosomal preparations
were incubated in 1.5-mL microtubes with 50 nm [3H]Glu
(2.33 TBq/mmol) in 1 mL CSF at 378C for 10 min, followed by
centrifugation at 16 000 gmax for 5 min using a Beckman
Microfuge. After thorough removal of the supernatants, the pellets
were homogenized in 6 mm Tris-maleate (pH 8.1) containing 2 mm
Asp, using an ultrasonic homogenizer (4710 series, Cole-Palmer
Instruments, Chicago, IL, USA) for 3 s, in order to lyse [3H]Glu-
loaded synaptosomes. As a control, the pellets were suspended in
CSF containing 2 mm Asp by extremely gentle pipetting or by
using a plastic homogenizing pestle. These suspensions were kept
on ice for 45 min and subsequently centrifuged at 16 000 gmax for
5 min. The supernatants were put onto a Whatman GF/C ®lter
under a constant vacuum of 10 mmHg in order to trap synaptic
vesicles; the ®lter was rinsed four times with 2.5 mL of ice-cold
0.15 m KCl. In some experiments, the supernatants obtained upon
bursting [3H]Glu-loaded synaptosomes were centrifuged for 60 min
at 200 000 gmax (50 000 r.p.m., Beckman 70.1Ti rotor) to pellet
synaptic vesicles. Radioactivity (V) retained on the ®lter or in the
synaptic vesicle pellet was measured by scintillation spectro-
photometry and divided by the total [3H]Glu (S) in synaptosomes at
the time of loading. The total [3H]Glu loaded into synaptosomes
was estimated from the amount of [3H]Glu in 0.1 mL of loaded
synaptosomes, determined by the ®ltration method. Vesicular Glu
content was expressed as:
V lysed 2 Vunlysed/S:
Neither Vlysed nor Vunlysed was affected by the presence of Glu
(2 mm) or Asp (2 mm) in the lysing solution. However, the former,
but not the latter, was reduced substantially by carbonyl cyanide
p-(tri¯uoromethoxy)-phenylhydrazone (FCCP; 20 mm), indicating
that Vlysed but not Vunlysed represents [
3H]Glu associated with the
synaptic vesicle. Compounds tested were incubated with synapto-
somes for the same period as for loading [3H]Glu.
Depolarization-induced calcium in¯ux into synaptosomes
Aliquots (10 mg protein) of synaptosomes were incubated at 378C
for 1.5 or 10 min in a solution (®nal volume, 0.1 mL) containing
45Ca (3 mCi) and unlabeled 50 nm Glu with or without 50 mm 4-AP
in Ca21-containing CSF. 4-Aminopyridine-induced calcium in¯ux
into synaptosomes was terminated by diluting with 2.5 mL of
ice-cold 0.15 m KCl, and the amount of 45Ca taken up was deter-
mined by the same method described for Glu uptake into synaptic
vesicles.
ATPase activity in synaptic vesicles
ATPase activity in RCSV was assayed by determination of free
inorganic phosphate liberated through incubation of RCSV with
ATP, according to Lanzetta et al. (1979), with minor modi®cations.
In brief, aliquots (40±50 mg) of RCSV were incubated in 0.1 mL of
the same incubation medium used for the assay for vesicular
uptake, in either the presence or absence of 2 mm ATP at 308 for
10 min. An aliquot (25 mL) of the reaction mixture was added to
0.2 mL of an ice-cold solution containing 0.034% malachite green
hydrochloride (Sigma), 1% (NH4)6Mo7O24´4H2O, 0.2% Tween-40
and 1 m HCl, followed by addition of 25 mL of 34% sodium
citrate´2H2O. The synaptic vesicle fraction was pre-incubated with
test compounds at 308C for 30 min in the incubation medium prior
to addition of ATP.
Measurement of membrane potential
Generation of the membrane potential across the synaptic vesicle
membrane (positive inside) was monitored by ¯uorescence
quenching of the membrane potential-sensitive dye oxanol V, with
excitation and emission wavelengths of 600 and 630 nm, respec-
tively, using a Fluorolog III ¯uorospectrophotometer. The incubation
mixture (®nal volume, 1.5 mL) contained 20 mm HEPES-KOH
(pH 7.4), 150 mm potassium gluconate, 4 mm MgSO4, 1.3 mm
oxanol V, synaptic vesicles (50 mg/mL) and 2 mm ATP (adjusted
to pH 7.4 with Tris-base). The mixture without ATP was pre-
incubated at 308C until oxanol V equilibrated with synaptic
vesicles, as judged by no signi®cant change in ¯uorescence
intensity. Addition of ATP (in 15 mL) caused rapid ¯uorescence
quenching. This was followed by addition of the proton ionophore
FCCP (1 mL of 12.5 mm stock in ethanol), which caused
dequenching of the ¯uorescence, indicating that ATP addition led
to generation of the membrane potential. Various amounts of Rose
Bengal (in a ®xed volume of 3 mL dimethylsulfoxide) were added
to the incubation mixture after formation of the membrane
potential; Rose Bengal exhibited concentration-dependent ¯uor-
escence quenching. Addition of FCCP led to varying amounts of
dequenching, depending upon the concentration of Rose Bengal.
The membrane potential in the absence or presence of Rose Bengal
was expressed in terms of fractional quenching as de®ned:
fractional quenching  Fd 2 Ft/Fo;
where Fo is the ¯uorescence intensity of oxanol V observed after
addition of synaptic vesicles, Ft the ¯uorescence intensity observed
after addition of the test agent Rose Bengal on top of ATP or
addition of ATP alone, and Fd the ¯uorescence intensity observed
after addition of the membrane potential dissipater FCCP.
Statistical analysis
Results are represented as mean ^ SEM and statistical signi®cance
was determined using the two-tailed Student's t-test. IC50 values
were estimated using the Macintosh deltagraph program, with
nonlinear regression analysis. Analysis of Lineweaver2Burk plot
and initial rate of uptake was performed using the IBM excel
program, with linear regression analysis.
Results
Inhibition of vesicular Glu uptake
We tested a variety of membrane-permeant organic com-
pounds, focusing in particular on ¯uorescein derivatives, for
the ability to inhibit glutamate uptake into isolated synaptic
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vesicles. We found that Rose Bengal (tetraiodo-tetrachloro-
¯uorescein) is one of the most potent inhibitors of all the
agents tested, whereas ¯uorescein is the least potent.
Figure 1 shows the chemical structure of Rose Bengal and
¯uorescein. Figure 2 shows that Rose Bengal inhibited
ATP-dependent vesicular Glu uptake in a concentration-
dependent manner at concentrations . 10 nm, whereas
¯uorescein exhibited no signi®cant inhibition up to 3 mm.
The IC50 value of Rose Bengal was determined to be
37 ^ 7 nm (n  11). Although ATP-independent Glu
uptake into RCSV was , 15% of total uptake, Rose Bengal
had no signi®cant effect on ATP-independent Glu uptake at
concentrations up to 1 mm (data not shown); however, it
caused < 50% inhibition at 50 mm.
Figure 3 shows a time course of vesicular Glu uptake in
the absence or presence of Rose Bengal or ¯uorescein,
following the standard 30-min pre-incubation with test
compounds. In the absence of test compounds, Glu uptake
increased linearly up to 1.5 min of incubation time and
reached equilibrium at 5 min. Rose Bengal was effective in
inhibiting Glu uptake throughout the incubation times
examined; it reduced not only the initial rate but also the
®nal level of uptake. Half time for reaching equilibrium (t1/2)
was not much affected by Rose Bengal; t1/2 values (min) in
the absence and presence of Rose Bengal were estimated
to be 1.0 ^ 0.3 and 1.4 ^ 0.2, respectively. In contrast,
¯uorescein caused no signi®cant change in Glu uptake
throughout the incubation times tested.
Calcium-dependent Glu release from synaptosomes
The potassium channel blocker 4-AP was used to induce
depolarization of the synaptosomal membrane (Nicholls
1989; McMahon and Nicholls 1991). We focused on the
initial rate of [3H]Glu release elicited by 4-AP in the
presence of Ca21. After 40 min superfusion, the basal
release of [3H]Glu from rat brain synaptosomes was
constant for the duration of the experiment (3 min) and
was not affected by replacing CaCl2 with EGTA in the
superfusion medium (data not shown). When [3H]Glu-
loaded synaptosomes were depolarized by exposure to
50 mm 4-AP in CSF containing Ca21, [3H]Glu release was
increased, which was fairly linear up to 1.5 min (Fig. 4). In
the Ca21-free perfusion medium, no signi®cant increase was
observed. The amounts of radioactive compounds released
by 4-AP during the 1.5-min superfusion period, in the
presence and absence of Ca21, were 9456 ^ 1252 and
676 ^ 462 d.p.m. respectively, over the basal ef¯ux level.
Further increase in 4-AP beyond 50 mm up to 500 mm failed
to elicit additional release.
Inhibition of 4-AP-evoked Glu release
We examined the effect of Rose Bengal and ¯uorescein on
4-AP-evoked [3H]Glu release from synaptosomes. Rose
Bengal at 0.6 mm led to complete inhibition of Glu release
Fig. 1 Chemical structure of Rose Bengal and ¯uorescein.
Fig. 2 Effect of various concentrations of Rose Bengal and ¯uores-
cein on ATP-dependent Glu uptake into synaptic vesicles. Rat crude
synaptic vesicles were incubated in the absence or presence of indi-
cated concentrations (®nal concentration) of Rose Bengal and ¯uor-
escein, and assayed for ATP-dependent Glu uptake, as described in
Materials and methods. Uptake activity was expressed as percen-
tage of control value obtained in absence of test compounds. Values
were mean ^SEM from four to six independent experiments.
Control values for Rose Bengal and ¯uorescein dose±response
curves were: 500 ^ 18 and 432 ^ 23 pmol/mg protein/10 min,
respectively.
Fig. 3 Effect of Rose Bengal and ¯uorescein on the time course of
vesicular Glu uptake. Following pre-incubation of RCSV with or with-
out Rose Bengal or ¯uorescein (100 nM) at 308C for 30 min, a
mixture of ATP and [3H]Glu was added to initiate vesicular [3H]Glu
uptake; uptake was allowed to occur for the various periods indi-
cated. Values indicate uptake activity in the presence of ATP, deter-
mined in four separate experiments (mean ^SEM).
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evoked by 4-AP in the presence of Ca21 throughout the
entire period tested, whereas ¯uorescein failed to affect the
4-AP-evoked release (Fig. 5). These compounds had no
effect on calcium-independent release or ef¯ux of Glu (data
not shown). These results indicate that Rose Bengal inhibits
4-AP-evoked Ca21-dependent Glu release. The inhibitory
effect was seen up to at least 3 min after application of
4-AP.
Figure 6 shows 4-AP-evoked [3H]Glu release from
synaptosomes as a function of the concentration of Rose
Bengal and ¯uorescein. Rose Bengal markedly inhibited the
release in a concentration-dependent manner, with an IC50
value of 137 ^ 24 nm (n  5). However, no signi®cant effect
was seen with ¯uorescein up to 3 mm. The inhibitory effect of
Rose Bengal was unaltered when synaptosomes were
incubated with the compound for 30 min before loading
[3H]Glu (data not shown). Rose Bengal (0.01±6 mm) did not
block 4-AP-induced calcium in¯ux into synaptosomes (data
not shown), indicating that Rose Bengal's inhibitory effect on
Glu release could not be attributed to prevention of an increase
in the synaptosomal calcium concentration, which is
required for evoked release of Glu.
Reduction of vesicular Glu content in the synaptosome
We have shown that Rose Bengal, but not ¯uorescein, was
remarkably effective in inhibiting not only ATP-dependent
Glu uptake into isolated synaptic vesicles, but also 4-AP-
evoked Glu release from synaptosomes. These ®ndings
suggested that Rose Bengal, but not ¯uorescein, reduces
the accumulation of Glu in synaptic vesicles within the
synaptosome. In an effort to assess this possibility, we
examined the effect of Rose Bengal and ¯uorescein on
intrasynaptosomal vesicular [3H]Glu content. We used
®ltration and centrifugation methods to measure vesicular
[3H]Glu content in the synaptosome. As shown in Fig. 7(a)
(®ltration method), Rose Bengal, but not ¯uorescein,
reduced vesicular [3H]Glu content. The IC50 value for the
former was determined to be 167 ^ 23 nm (n  13).
Similar dose±response curves and IC50 values were
obtained using the centrifugation method (Fig. 7b); the
IC50 value was determined to be 137 ^ 52 nm (n  4). The
®ltration method, simpler and speedier, yielded less variable
Fig. 4 Effect of 4-AP on Glu release from synaptosomes in the
presence or absence of Ca21. After [3H]Glu-loaded synaptosomes
were washed for 40.5 min by superfusion with either normal Ca-
containing CSF (1Ca) or Ca21-free medium in CSF (±Ca), 4-AP
(50 mM) was applied to depolarize the synaptosomal membrane. The
superfusate was collected every 10 s, and radioactivity determined.
Values are obtained using four different synaptosomal preparations.
Fig. 5 Effect of presence of Rose Bengal and ¯uorescein during
[3H]Glu loading on time course of subsequent 4-AP-evoked Glu
release. Synaptosomes were incubated at 378C for 10 min with
50 nM [3H]Glu in the absence or presence of 0.6 mM each Rose
Bengal or ¯uorescein in Ca21-containing CSF, followed by 40 min
superfusion (in absence of test agents), as described in Materials
and methods. [3H]Glu release was then induced by application of
50 mM 4-AP. Values are mean ^SEM from four separate experi-
ments.
Fig. 6 Effect of presence of various concentrations of Rose Bengal
and ¯uorescein during [3H]Glu loading on subsequent 4-AP-evoked
Glu release. Synaptosomes were co-incubated at 378C for 10 min
with 50 nM [3H]Glu and indicated concentrations of Rose Bengal or
¯uorescein in CSF. After 40 min superfusion in the absence of test
agents, synaptosomes were subjected to 4-AP-induced release.
[3H]Glu released by 4-AP during the 1.5-min period was determined.
Values are mean ^SEM from four separate experiments.
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results, however. This is in accord with the notion that
synaptic vesicles in the synaptosomal lysate can be trapped
on the ®lter. This indicates that the simpler ®ltration method
can be used to ef®ciently estimate vesicular neurotransmitter
content. It may be noted that the Rose Bengal dose±
response curve for Glu release is highly similar, if not
identical, to that for vesicular Glu content. This argues for
the notion that the inhibitory effect of Rose Bengal on Glu
release is largely mediated by inhibition of vesicular Glu
uptake into synaptic vesicles in the synaptosome. These
results are also consistent with our observation that Rose
Bengal permeates the synaptosomal membrane with ease.
Kinetic analysis for Rose Bengal inhibition of vesicular
Glu uptake
In an effort to understand the mechanism of the inhibition of
vesicular uptake by Rose Bengal, kinetic experiments were
carried out with isolated synaptic vesicles in the absence and
presence of 30 and 60 nm Rose Bengal. As shown in Fig. 8,
Rose Bengal had little, if any, effect on the Km value for
Glu. The Km value was determined to be 1.61 ^ 0.20 mm in
the absence of Rose Bengal, which is in agreement with
values reported previously (Naito and Ueda 1985; Tabb and
Ueda 1991; Fykse et al. 1992; Wolosker et al. 1996;
Carrigan et al. 1999). The Km values for Glu in the presence
of 30 and 60 nm were 1.25 ^ 0.16 and 1.26 ^ 0.21 mm,
respectively. In contrast to Km, Vmax was signi®cantly
Fig. 7 Effect of various concentrations of Rose Bengal and ¯uores-
cein on vesicular [3H]Glu content in the synaptosome. Synapto-
somes were incubated at 378C for 10 min with 50 nM [3H]Glu in the
presence of indicated concentrations of Rose Bengal or ¯uorescein.
[3H]Glu-loaded synaptosomes were lysed and vesicular [3H]Glu
content determined either by the ®ltration method (a) or the centrifu-
gation method (b), as described in Materials and methods. Values
represent the percentage of control values determined in the
absence of test compounds, and were obtained from four indepen-
dent experiments using four separate synaptosome preparations
(mean ^SEM). Control values (% of the total amount taken up into
synaptosomes) for the Rose Bengal and ¯uorescein dose±response
curves determined by the ®ltration method (a) were 0.541 ^ 0.076
and 0.490 ^ 0.04, respectively. Those determined by the centrifuga-
tion method (b) were 0.668 ^ 0.025 and 0.762 ^ 0.046, respectively.
Fig. 8 Effect of Rose Bengal on kinetic parameters of vesicular
glutamate uptake system. The RCSV preparation was pre-incubated
at 308C for 30 min in the absence or presence of 30 and 60 nM
Rose Bengal. Vesicular [3H]Glu uptake was initiated by addition of a
mixture of ATP (®nal concentration, 2 mM) and various concentra-
tions of unlabeled Glu, together with a ®xed amount of [3H]Glu
(74 kBq). Uptake was allowed to occur for 2 min at 308C. Values are
mean ^SEM from four separate experiments.
Fig. 9 Effect of various concentrations of Rose Bengal and ¯uores-
cein on vesicular ATPase activity. The RCSV preparation was incu-
bated at 308C for 10 min in presence of indicated concentrations of
Rose Bengal and ¯uorescein, prior to initiation of ATPase activity
with addition of ATP, as described in Materials and methods.
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altered by Rose Bengal; Vmax values in the presence of 0, 30
and 60 nm Rose Bengal were 3.47 ^ 0.35, 1.56 ^ 0.27**
and 0.80 ^ 0.12** nmol/min/mg protein, respectively
(**p , 0.01, compared with the value obtained in the
absence of Rose Bengal). Thus, Rose Bengal appears to act
as a noncompetitive inhibitor with respect to Glu. The Ki
value of Rose Bengal determined from the Dixon plot was
19.4 ^ 0.8 nm (n  4).
Vesicular ATPase activity and synaptosomal Glu uptake
Because vesicular Glu uptake is driven by an electrochemi-
cal protein gradient generated by V-type proton-pump
ATPase, we tested Rose Bengal for the ability to inhibit
this enzyme. Figure 9 shows that, although vesicular H1-
pump ATPase is subject to inhibition by Rose Bengal, its
potency (IC50  918 ^ 90 nm; n  4) is far below that
seen in vesicular Glu uptake inhibition. This indicates that
the inhibitory effect of Rose Bengal in the low concentration
range is not accounted for by its ability to inhibit H1-pump
ATPase at higher concentrations. Fluorescein had no effect
up to 50 mm.
The Na1-dependent Glu uptake system in the plasma
membrane is distinct from the vesicular glutamate uptake
system (Naito and Ueda 1985; Winter and Ueda 1993). It
was hence of interest to determine the effect of Rose Bengal
on such a Glu transport system. We tested Rose Bengal for
the ability to affect Na1-dependent Glu uptake into
synaptosomes. Rose Bengal was also capable of suppressing
synaptosomal Glu uptake; however, it showed inhibition at
substantially high concentrations compared with those
demonstrated to be effective with vesicular glutamate
uptake. Rose Bengal's IC50 value for synaptosomal uptake
was 2.2 ^ 0.7 mm (n  11), which is 60 times higher than
that for uptake into isolated synaptic vesicles.
Effect of Rose Bengal on membrane potential
The observations that Rose Bengal is a noncompetitive
inhibitor with respect to glutamate, whereas it exhibits little,
if any, inhibition of ATP hydrolysis, led us to consider the
possibility that Rose Bengal may achieve glutamate uptake
inhibition by dissipating the membrane potential across the
synaptic vesicle membrane. The experimental results shown
in Fig. 10 indicate that the membrane potential generated by
H1-pump ATPase is hardly affected by Rose Bengal at the
concentration (37 nm) which causes 50% inhibition of
vesicular glutamate uptake. It is noted, however, that Rose
Bengal is capable of dissipating the membrane potential at
high concentrations. Its IC50 value for dissipating the mem-
brane potential was estimated to be < 4.3 mm. It is feasible
that Rose Bengal is interacting with two af®nity sites (IC50
< 0.23 and 6 mm). In either case, Rose Bengal's IC50 for
membrane dissipation is signi®cantly higher than that for
vesicular glutamate uptake inhibition, indicating that
inhibition of vesicular glutamate uptake by Rose Bengal is
Fig. 10 Effect of various concentrations of Rose Bengal on
membrane potential in synaptic vesicles. After oxanol V (1.3 mM)
was allowed to equilibrate with synaptic vesicles as described in
Materials and methods, ATP was added (in 15 mL), resulting in a
®nal concentration of 2 mM. Various amounts of Rose Bengal were
then added (in 3 mL), resulting in ®nal concentrations of 0.075, 0.15,
0.225, 0.6, 2.5, 6.2, 12.4 and 24.8 mM, followed by addition of FCCP
(in 1 mL), resulting in a ®nal concentration of 8.33 mM. Membrane
potential was monitored by measuring the ¯uorescence quenching of
oxanol V. Fractional quenching, as de®ned in Materials and meth-
ods, was plotted as a function of the concentration of Rose Bengal.
(a) Time course tracing of ¯uorescence quenching before and after
addition of 0.075, 6.2 and 24.8 mM Rose Bengal. (b) Membrane
potential as a function of various concentrations of Rose Bengal as
indicated.
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unlikely to be mediated by dissipating the membrane
potential.
Discussion
We found that Rose Bengal is one of the most potent,
noncompetitive inhibitors of Glu uptake into synaptic
vesicles, of all the ¯uorescein-related compounds tested.
Unmodi®ed ¯uorescein was quite ineffective in producing
inhibition of vesicular uptake. Rose Bengal, when applied to
synaptosomes extracellularly, led to a reduction, with
similar degrees of potency, in both vesicular Glu content
in the synaptosome and in the amount of released Glu in
a calcium- and depolarization-dependent manner. These
observations not only support the role of synaptic vesicles in
Glu release in the CNS, but also constitute evidence that the
amount of exocytotically released Glu can be changed by
varying its content in the synaptic vesicle situated within the
nerve ending. The potency observed for Rose Bengal's
effects on Glu vesicular content and release is lower than
that for Glu uptake into isolated synaptic vesicles; this could
be ascribed to the negative (inside) resting potential of the
synaptosome. Such a potential would prevent quantitative
equilibration of Rose Bengal due to its negative charge,
requiring a higher extrasynaptosomal concentration in order
to achieve the same effective concentration observed with
isolated synaptic vesicles. No experiments reported pre-
viously measured both exocytotic release and vesicular
accumulation of Glu (or any transmitter for that matter),
using the same preparation. Our study could provide a lead
for the development of a drug to block vesicular glutamate
storage and release in vivo. We also examined the effect of
Rose Bengal on the initial generation of membrane potential
by adding it to the incubation mixture prior to the addition of
ATP. It had no signi®cant effect on the process of membrane
potential formation, namely, proton translocation by V-type
ATPase, at up to 0.225 mm (data not shown).
The precise site of action of Rose Bengal remains to be
determined. The kinetic data obtained rule out the possibility
that it interacts with the Glu-binding site of the vesicular Glu
transporter. The potent inhibitory effect of Rose Bengal
could not be mediated by inhibition of vesicular H1-pump
ATPase. The ATPase activity was hardly affected by those
low concentrations which were suf®cient to bring about
substantial inhibition of vesicular Glu uptake. Moreover,
Rose Bengal at 37 nm (the concentration which caused 50%
inhibition of vesicular glutamate uptake) had no signi®cant
effect on dissipation of the membrane potential (Fig. 10), on
proton translocation, or on ef¯ux of accumulated [3H]Glu
(data not shown). These observations raise the possibility
that Rose Bengal is acting on an allosteric site of the
vesicular Glu transporter, a site involved in sensing the
electrochemical proton gradient or Glu translocation across
the vesicle membrane.
Rose Bengal is different in at least four respects from
Trypan Blue, the most potent vesicular Glu uptake inhibitor
reported to date (Roseth et al. 1998). Firstly, Rose Bengal
has a pharmacophore which does not resemble that of
Trypan Blue; the former bears the ¯uorescein backbone
structure containing a carboxyl group, whereas the latter is a
diazo compound containing amino and sulfon groups like
Evans Blue and Chicago Sky Blue. Secondly, Rose Bengal
(Ki  19 nm) is somewhat more potent than Trypan Blue
(Ki  50 nm). Thirdly, the former inhibits vesicular Glu
uptake in a noncompetitive manner, whereas the latter
competes with Glu. Fourthly, the former is a membrane
permeable agent, whereas the latter does not permeate the
membrane with ease; this property would render Trypan
Blue, when applied extracellularly, ineffective in altering
vesicular glutamate content in the nerve ending.
The vesicular Glu uptake system differs from the plasma
membrane Glu re-uptake system in several respects includ-
ing substrate speci®city, sensitivity to chloride and the
nature of the immediate driving force (OÈ zkan and Ueda
1998). Here, we have shown that Rose Bengal has differ-
ential effects on Glu uptake into isolated synaptic vesicles
and into synaptosomes; it exhibits more potent inhibition on
the former process than on the latter. This signi®cant
difference in response to Rose Bengal provides additional
evidence for the vesicular Glu uptake system being a distinct
molecular entity from the plasma membrane transport
system. Thus, the differential effects of Rose Bengal could
be used as another parameter to distinguish between these
two classes of Glu transport systems.
Our observation that Rose Bengal reduces vesicular
[3H]Glu content within the synaptosome and decreases
exocytotically released [3H]Glu, with similar relatively high
potencies (IC50  1372167 nm), is compatible with the
notion that Rose Bengal readily permeates the synaptosomal
plasma membrane and subsequently elicits these effects.
Rose Bengal's inhibitory effect on vesicular uptake could
not be ascribed simply to its interaction with the membrane
lipid, given the high af®nity of Rose Bengal for the vesicular
Glu uptake system (Ki  19 nm); it is likely to be mediated
by an interaction with a speci®c hydrophobic domain(s) of a
protein component(s) of the ATP-dependent vesicular
uptake system.
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